marketcaparena

BHVN

Biohaven Ltd.

Company overview

Market capitalization
$2.00B
Employees
274
Latest publication
2026-09-29
About Biohaven Ltd.

Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide. It develops BHV-1300, which is in Phase 2 clinical trial to treat Graves' disease and rheumatoid arthritis; BHV-1400 that is in Phase 2 clinical trial for treating IgA nephropathy; BHV-1600, which is in Phase 1 clinical trial for the treatment of peripartum cardiomyopathy; BHV-8000 that is in Phase 3 clinical trial for treating Parkinson's disease; Opakalim, which is in Phase 3 clinical trial for the treatment of focal epilepsy; BHV-2100 that is in Phase 2 clinical trial for the treatment of pain disorders; and BHV-2000, which is in Phase 2 clinical trial for treating obesity. The company is also developing BHV-1510 that is in Phase 2 clinical trial for the treatment of advanced or metastatic epithelial tumors; and BHV-1530, which is in Phase 2 clinical trial for treating urothelial cancer and other tumors. In addition, its preclinical product pipeline includes BHV-1310 for treating myasthenia gravis; BHV-1320 for treating immune mediated-diseases; BHV-1450 for treating Pemphigus, MuSK MG, and LGI-1 Encephalitis; BHV-1420 for treating membranous nephropathy; BHV-1440 for treating Graves' disease and TED; BHV-6500 for treating type 1 diabetes; BHV-1490 for treating IgM neuropathy and Waldenstrom's; BHV-8100 for treating neurodegenerative diseases; and BHV-1955 for treating tinnitus. The company was formerly known as Biohaven Research Ltd. and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Total Revenue0USD0USD0USD0USD0USD3,836,000USD0USD0USD
Research Development103,827,000USD121,945,000USD141,169,000USD184,367,000USD187,584,000USD167,473,000USD157,607,000USD314,819,000USD
Selling General Administrative26,601,000USD20,789,000USD28,213,000USD27,334,000USD33,977,000USD22,458,000USD20,561,000USD18,953,000USD
Total Operating Expenses130,428,000USD141,774,000USD168,277,000USD211,701,000USD221,561,000USD189,931,000USD178,168,000USD333,772,000USD
Operating Income-130,428,000USD-142,734,000USD-169,382,000USD-211,701,000USD-221,561,000USD-189,931,000USD-178,168,000USD-333,772,000USD
Income Before Tax-130,260,000USD-145,204,000USD-173,222,000USD-197,886,000USD-221,068,000USD-186,795,000USD-160,363,000USD-319,594,000USD
Income Tax Expense272,000USD351,000USD221,000USD261,000USD609,000USD48,000USD-59,000USD177,000USD
Tax Provision272,000USD351,000USD221,000USD261,000USD609,000USD48,000USD-59,000USD177,000USD
Net Income-130,532,000USD-145,555,000USD-173,443,000USD-198,147,000USD-221,677,000USD-186,843,000USD-160,304,000USD-319,771,000USD
Net Income From Continuing Ops-130,532,000USD-145,555,000USD-173,443,000USD-198,147,000USD-221,677,000USD-186,843,000USD-160,304,000USD-319,771,000USD
Ebit-130,428,000USD-145,204,000USD-173,222,000USD-211,701,000USD-221,561,000USD-189,931,000USD-178,168,000USD-333,772,000USD
Ebitda-128,062,000USD-142,631,000USD-172,117,000USD-209,723,000USD-219,315,000USD-187,470,000USD-176,174,000USD-331,818,000USD
Depreciation And Amortization2,366,000USD2,573,000USD1,105,000USD1,978,000USD2,246,000USD2,461,000USD1,994,000USD1,954,000USD
Reconciled Depreciation2,366,000USD2,573,000USD3,125,000USD1,978,000USD2,246,000USD2,461,000USD1,994,000USD1,954,000USD
Total Other Income Expense Net168,000USD-2,470,000USD-3,840,000USD13,815,000USD493,000USD3,136,000USD17,805,000USD14,178,000USD
Cost Of Revenue—960,000USD1,105,000USD—1,014,999USD1,918,000USD1,000,000USD977,000USD
Gross Profit—-960,000USD-1,105,000USD—-1,014,999USD1,918,000USD-1,000,000USD-977,000USD
Selling And Marketing Expenses———————977,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20172017-12-31 · USD
Total Revenue0USD0USD0USD0USD462,509,000USD0USD——
Cost Of Revenue4,139,999USD3,923,000USD3,369,000USD1,386,000USD1,393,000USD72,000USD——
Gross Profit-4,139,999USD-3,923,000USD-3,369,000USD-1,386,000USD370,845,000USD-72,000USD——
Research Development635,065,000USD795,871,000USD373,281,000USD437,072,000USD181,486,000USD98,460,000USD344,673,000USD—
Selling General Administrative106,173,000USD89,240,000USD62,770,000USD130,860,000USD37,414,000USD16,046,000USD134,449,000USD—
Total Operating Expenses741,238,000USD885,111,000USD436,051,000USD567,932,000USD218,900,000USD114,506,000USD479,122,000USD—
Operating Income-745,378,000USD-885,111,000USD-436,051,000USD-567,932,000USD-218,900,000USD-114,506,000USD-479,122,000USD—
Income Before Tax-737,380,000USD-845,687,000USD-409,551,000USD-569,841,000USD-212,430,000USD-118,668,000USD-528,386,000USD—
Income Tax Expense1,442,000USD735,000USD-1,383,000USD438,000USD1,366,000USD-134,000USD419,000USD—
Tax Provision1,442,000USD735,000USD-1,383,000USD438,000USD1,366,000USD0USD——
Net Income-738,822,000USD-846,422,000USD-408,168,000USD-570,279,000USD-213,796,000USD-118,668,000USD-528,805,000USD—
Net Income From Continuing Ops-738,822,000USD-846,422,000USD-408,168,000USD-570,279,000USD-848,396,000USD-118,668,000USD——
Ebit-737,380,000USD-885,111,000USD-436,051,000USD-567,932,000USD-218,900,000USD-114,506,000USD-479,122,000USD—
Ebitda-727,458,000USD-877,256,000USD-429,139,000USD-566,546,000USD-217,507,000USD-114,434,000USD-479,122,000USD—
Depreciation And Amortization9,922,000USD7,855,000USD6,912,000USD1,386,000USD1,393,000USD72,000USD171,860USD52,516USD
Reconciled Depreciation9,922,000USD7,855,000USD6,912,000USD1,386,000USD1,393,000USD72,000USD——
Total Other Income Expense Net7,998,000USD39,424,000USD26,500,000USD-1,909,000USD6,470,000USD-4,162,000USD-49,264,000USD—
Interest Expense———1,386,000USD41,551,000USD—12,711,000USD—
Net Income Applicable To Common Shares———-570,279,000USD-846,586,000USD-118,668,000USD——
Non Operating Income Net Other————-65,435,000USD———
Minority Interest————-1,810,000USD———
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Total Assets466,406,000USD451,447,000USD409,123,000USD550,415,000USD458,946,000USD615,107,000USD510,523,000USD582,641,000USD
Intangible Assets18,400,000USD18,400,000USD18,400,000USD18,400,000USD18,400,000USD18,400,000USD18,400,000USD18,400,000USD
Other Current Assets37,832,000USD49,192,000USD63,398,000USD69,847,000USD60,008,000USD49,884,000USD56,366,000USD66,798,000USD
Total Liab336,906,000USD399,375,000USD426,283,000USD415,828,000USD199,451,000USD191,671,000USD194,517,000USD198,901,000USD
Total Stockholder Equity129,500,000USD52,072,000USD-17,160,000USD134,587,000USD259,495,000USD423,436,000USD316,006,000USD383,740,000USD
Other Current Liab41,653,000USD104,291,000USD90,020,000USD100,000,000USD140,184,000USD132,395,000USD128,874,000USD135,398,000USD
Common Stock2,132,908,000USD1,934,276,000USD1,743,740,000USD1,743,109,000USD1,689,346,000USD1,656,702,000USD1,381,699,000USD1,298,553,000USD
Capital Stock2,132,908,000USD1,934,276,000USD1,743,740,000USD1,743,109,000USD1,689,346,000USD1,656,702,000USD1,381,699,000USD1,298,553,000USD
Retained Earnings-2,215,068,000USD-2,084,536,000USD-1,938,981,000USD-1,765,538,000USD-1,567,391,000USD-1,345,714,000USD-1,158,871,000USD-998,567,000USD
Good Will1,390,000USD1,390,000USD1,390,000USD1,390,000USD1,390,000USD1,390,000USD1,390,000USD1,390,000USD
Cash273,074,000USD229,957,000USD184,847,000USD165,797,000USD98,417,000USD99,134,000USD84,390,000USD239,147,000USD
Cash And Short Term Investments347,817,000USD319,137,000USD260,217,000USD404,980,000USD322,749,000USD485,991,000USD378,816,000USD436,948,000USD
Total Current Assets385,649,000USD368,329,000USD323,615,000USD474,827,000USD382,757,000USD538,472,000USD440,500,000USD511,268,000USD
Total Current Liabilities52,075,000USD115,934,000USD113,023,000USD124,324,000USD164,034,000USD154,226,000USD152,294,000USD156,207,000USD
Net Debt7,201,000USD48,901,000USD129,329,000USD125,766,000USD-62,905,000USD-62,550,000USD-55,402,000USD-209,404,000USD
Short Long Term Debt Total280,275,000USD278,858,000USD314,176,000USD291,563,000USD35,512,000USD36,584,000USD28,988,000USD29,743,000USD
Long Term Debt241,912,000USD238,900,000USD268,270,000USD257,070,000USD————
Short Term Investments74,743,000USD89,180,000USD75,370,000USD239,183,000USD224,332,000USD386,857,000USD294,426,000USD197,801,000USD
Accounts Payable10,422,000USD11,643,000USD17,491,000USD19,628,000USD19,142,000USD18,029,000USD19,744,000USD17,259,000USD
Property Plant Equipment Net15,256,000USD15,964,000USD62,722,000USD52,835,000USD53,222,000USD53,711,000USD47,184,000USD48,568,000USD
Property Plant Equipment Gross75,490,000USD77,148,000USD78,108,000USD67,116,000USD66,443,000USD65,917,000USD58,385,000USD58,769,000USD
Accumulated Other Comprehensive Income8,302,000USD8,348,000USD36,000USD-3,000USD73,000USD79,000USD140,000USD-78,000USD
Common Stock Shares Outstanding147,615,197shares120,187,689shares105,815,038shares102,372,820shares101,943,000shares101,055,000shares94,372,000shares87,766,000shares
Non Current Assets Total80,757,000USD83,118,000USD85,508,000USD75,588,000USD76,189,000USD76,635,000USD70,022,000USD71,373,000USD
Non Current Liabilities Total284,831,000USD283,441,000USD313,260,000USD291,504,000USD35,417,000USD37,445,000USD42,223,000USD42,694,000USD
Non Current Liabilities Other4,556,000USD4,583,000USD4,596,000USD4,637,000USD4,613,000USD4,663,000USD4,591,000USD4,321,000USD
Non Currrent Assets Other45,711,000USD47,364,000USD2,996,000USD2,963,000USD3,177,000USD3,134,000USD3,048,000USD3,015,000USD
Net Working Capital333,574,000USD252,395,000USD210,592,000USD350,503,000USD218,723,000USD384,246,000USD288,206,000USD355,061,000USD
Unclassified Non Current Liabilities38,363,000USD39,958,000USD40,394,000USD29,797,000USD30,804,000USD32,782,000USD37,632,000USD38,373,000USD
Unclassified Equity-1,929,550,000USD-1,740,292,000USD-1,565,695,000USD-1,586,090,000USD-1,551,879,000USD-1,544,333,000USD-1,288,661,000USD-1,214,721,000USD
Short Term Debt——5,512,000USD4,696,000USD4,708,000USD3,802,000USD3,676,000USD3,550,000USD
Net Receivables—————2,597,000USD5,318,000USD7,522,000USD
Other Assets——————1,000USD1USD
Inventory——————-5,318,000USD—
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets451,447,000USD615,107,000USD513,212,000USD661,783,000USD142,061,000USD111,499,000USD344,264,000USD290,012,000USD
Intangible Assets18,400,000USD18,400,000USD18,400,000USD18,400,000USD18,400,000USD39,087,000USD——
Other Current Assets49,192,000USD49,884,000USD47,375,000USD75,488,000USD2,121,000USD10,000USD11,554,000USD8,090,000USD
Total Liab399,375,000USD191,671,000USD85,237,000USD123,012,000USD47,370,000USD34,718,000USD351,688,000USD139,092,000USD
Total Stockholder Equity52,072,000USD423,436,000USD427,975,000USD538,771,000USD94,691,000USD76,781,000USD-7,424,000USD150,920,000USD
Other Current Liab104,291,000USD132,395,000USD36,538,000USD76,299,000USD37,160,000USD27,119,000USD52,102,000USD8,782,000USD
Common Stock1,934,276,000USD1,656,702,000USD887,528,000USD615,742,000USD1,676,792,000USD1,249,547,000USD881,426,000USD554,384,000USD
Capital Stock1,934,276,000USD1,656,702,000USD887,528,000USD615,742,000USD0USD———
Retained Earnings-2,084,536,000USD-1,345,714,000USD-499,292,000USD-91,124,000USD-2,585,755,000USD-1,739,169,000USD-972,373,000USD-443,568,000USD
Good Will1,390,000USD1,390,000USD1,390,000USD1,390,000USD1,390,000USD0USD——
Cash229,957,000USD99,134,000USD248,402,000USD204,877,000USD76,057,000USD82,506,000USD316,727,000USD264,249,000USD
Cash And Short Term Investments319,137,000USD485,991,000USD381,819,000USD465,341,000USD76,057,000USD82,506,000USD316,727,000USD264,249,000USD
Total Current Assets368,329,000USD538,472,000USD442,446,000USD586,968,000USD94,823,000USD89,756,000USD328,281,000USD272,339,000USD
Total Current Liabilities115,934,000USD154,226,000USD55,423,000USD90,021,000USD41,935,000USD29,877,000USD66,173,000USD19,534,000USD
Net Debt48,901,000USD-62,550,000USD-217,525,000USD-171,277,000USD550,663,000USD184,952,000USD-316,727,000USD-146,734,000USD
Short Long Term Debt Total278,858,000USD36,584,000USD30,877,000USD33,600,000USD627,159,000USD267,458,000USD—117,515,000USD
Long Term Debt238,900,000USD———626,720,000USD———
Short Term Investments89,180,000USD386,857,000USD133,417,000USD260,464,000USD192,648,000USD223,185,000USD——
Accounts Payable11,643,000USD18,029,000USD15,577,000USD10,703,000USD4,775,000USD2,758,000USD14,071,000USD10,752,000USD
Property Plant Equipment Net15,964,000USD53,711,000USD48,576,000USD52,440,000USD18,232,000USD13,560,000USD8,152,000USD6,248,000USD
Property Plant Equipment Gross77,148,000USD65,917,000USD56,859,000USD57,354,000USD21,574,000USD15,265,000USD——
Accumulated Other Comprehensive Income8,348,000USD79,000USD-65,000USD284,000USD-73,000USD314,000USD——
Common Stock Shares Outstanding107,624,885shares91,234,000shares71,201,000shares44,741,000shares39,375,944shares39,375,944shares48,490,000shares48,489,890shares
Non Current Assets Total83,118,000USD76,635,000USD70,766,000USD74,815,000USD47,238,000USD21,743,000USD15,983,000USD17,673,000USD
Non Current Liabilities Total283,441,000USD37,445,000USD29,814,000USD32,991,000USD5,435,000USD4,841,000USD285,515,000USD119,558,000USD
Non Current Liabilities Other4,583,000USD4,663,000USD2,245,000USD2,410,000USD586,189,000USD4,841,000USD——
Non Currrent Assets Other47,364,000USD3,134,000USD2,400,000USD2,585,000USD3,216,000USD1,007,000USD7,831,000USD11,425,000USD
Net Working Capital252,395,000USD384,246,000USD387,023,000USD496,947,000USD52,888,000USD59,879,000USD——
Unclassified Non Current Liabilities39,958,000USD32,782,000USD27,569,000USD28,171,000USD-1,223,222,000USD-1,912,000USD285,515,000USD119,558,000USD
Unclassified Equity-1,740,292,000USD-1,544,333,000USD-847,724,000USD-601,873,000USD1,003,727,000USD566,089,000USD83,523,000USD40,104,000USD
Short Term Debt—3,802,000USD3,308,000USD3,019,000USD439,000USD675,000USD——
Net Receivables—2,597,000USD13,252,000USD46,139,000USD9,911,000USD120,111,000USD——
Other Assets——1USD2,585,000USD3,216,000USD1,007,000USD——
Inventory——-396,000USD56,157,000USD6,734,000USD39,563,000USD——
Other Liab———2,410,000USD2,638,000USD1,912,000USD——
Current Deferred Revenue———-38,231,000USD-439,000USD-675,000USD——
Long Term Investments———0USD6,000,000USD7,176,000USD——
Net Tangible Assets———518,685,000USD-735,818,000USD16,781,000USD——
Unclassified Current Assets———-56,157,000USD-192,648,000USD-375,619,000USD——
Unclassified Non Current Assets———-2,585,000USD-3,216,000USD-40,094,000USD——
Deferred Long Term Liab————13,110,000USD———
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income-130,532,000USD-145,555,000USD-173,443,000USD-198,147,000USD-221,677,000USD-186,843,000USD-160,304,000USD-319,771,000USD
Depreciation2,366,000USD2,573,000USD3,125,000USD1,978,000USD2,246,000USD2,461,000USD1,994,000USD977,000USD
Stock Based Compensation28,286,000USD16,952,000USD21,535,000USD20,812,000USD53,062,000USD12,694,000USD12,160,000USD12,232,000USD
Other Non Cash Items3,033,000USD5,193,000USD6,078,000USD-11,137,000USD5,610,000USD6,961,000USD-15,643,000USD174,305,000USD
Change In Working Capital-53,071,000USD-9,825,000USD-3,011,000USD18,558,000USD-4,365,000USD-6,015,000USD20,517,000USD-23,309,000USD
Total Cash From Operating Activities-149,918,000USD-130,662,000USD-145,716,000USD-167,936,000USD-165,124,000USD-170,742,000USD-141,276,000USD-167,798,000USD
Capital Expenditures0USD-8,000USD-13,000USD-233,000USD-461,000USD-49,000USD-611,000USD-2,949,000USD
Free Cash Flow-149,918,000USD-130,670,000USD-145,729,000USD-168,169,000USD-165,585,000USD-170,791,000USD-141,887,000USD-170,747,000USD
Investments15,212,000USD-13,731,000USD164,967,000USD-15,546,000USD164,879,000USD-87,676,000USD-93,398,000USD-97,931,000USD
Total Cashflows From Investing Activities15,212,000USD-13,739,000USD164,967,000USD-15,546,000USD164,879,000USD-87,676,000USD-93,398,000USD-97,931,000USD
Total Cash From Financing Activities179,016,000USD188,796,000USD122,000USD249,830,000USD369,000USD272,853,000USD80,375,000USD321,123,000USD
Issuance Of Capital Stock178,884,000USD189,175,000USD0USD0USD0USD271,284,000USD76,361,000USD—
Change In Cash44,326,000USD44,395,000USD19,387,000USD66,308,000USD147,000USD14,523,000USD-154,299,000USD54,797,000USD
Begin Period Cash Flow232,779,000USD188,384,000USD168,997,000USD102,689,000USD102,542,000USD88,019,000USD242,318,000USD184,506,000USD
End Period Cash Flow277,105,000USD232,779,000USD188,384,000USD168,997,000USD102,689,000USD102,542,000USD88,019,000USD239,303,000USD
Other Cashflows From Financing Activities179,016,000USD-194,000USD122,000USD249,830,000USD369,000USD1,569,000USD4,014,000USD238,000USD
Unclassified Financing Cash Flow-178,884,000USD187,157,000USD———259,783,000USD—320,885,000USD
Net Borrowings—0USD0USD———0USD—
Sale Purchase Of Stock—1,833,000USD———11,501,000USD——
Other Cashflows From Investing Activities——-20,000USD-1,829,000USD——391,000USD—
Unclassified Investing Cash Flow———2,062,000USD———2,949,000USD
Unclassified Operating Cash Flow———————-12,232,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-738,822,000USD-846,422,000USD-408,168,000USD-570,279,000USD-213,796,000USD-118,668,000USD-528,805,000USD-240,922,000USD
Depreciation9,922,000USD7,855,000USD6,912,000USD1,386,000USD1,393,000USD72,000USD——
Stock Based Compensation112,361,000USD71,963,000USD28,787,000USD193,556,000USD65,639,000USD29,500,000USD54,972,000USD16,925,000USD
Other Non Cash Items5,744,000USD167,340,000USD16,131,000USD106,252,000USD-740,000USD4,162,000USD93,183,000USD21,466,000USD
Change In Working Capital1,357,000USD16,811,000USD24,613,000USD-28,604,000USD1,664,000USD8,977,000USD3,319,000USD5,390,000USD
Total Cash From Operating Activities-609,438,000USD-582,453,000USD-331,725,000USD-297,689,000USD-145,840,000USD-75,957,000USD-377,331,000USD-197,141,000USD
Capital Expenditures-715,000USD-4,049,000USD-3,048,000USD-41,074,000USD-938,000USD-2,697,000USD-2,534,000USD-4,165,000USD
Free Cash Flow-610,153,000USD-586,502,000USD-334,773,000USD-338,763,000USD-146,778,000USD-78,654,000USD-379,865,000USD-201,306,000USD
Investments303,125,000USD-244,974,000USD129,830,000USD-304,790,000USD28,270,000USD-2,697,000USD——
Total Cashflows From Investing Activities300,561,000USD-244,974,000USD129,830,000USD-304,790,000USD944,000USD-2,697,000USD-3,784,000USD-10,540,000USD
Net Borrowings250,000,000USD0USD0USD—420,441,000USD———
Total Cash From Financing Activities439,117,000USD677,774,000USD211,908,000USD767,597,000USD138,447,000USD152,242,000USD434,593,000USD340,462,000USD
Sale Purchase Of Stock1,833,000USD11,501,000USD——345,626,000USD———
Issuance Of Capital Stock189,175,000USD666,165,000USD243,225,000USD283,804,000USD0USD0USD——
Change In Cash130,237,000USD-149,578,000USD9,516,000USD165,547,000USD-6,449,000USD73,588,000USD53,478,000USD132,781,000USD
Begin Period Cash Flow102,542,000USD252,120,000USD242,604,000USD77,057,000USD83,506,000USD9,918,000USD264,249,000USD131,468,000USD
End Period Cash Flow232,779,000USD102,542,000USD252,120,000USD242,604,000USD77,057,000USD83,506,000USD317,727,000USD264,249,000USD
Other Cashflows From Investing Activities-1,849,000USD391,000USD—-4,000,000USD-28,270,000USD-43,100,000USD-1,250,000USD—
Other Cashflows From Financing Activities-194,000USD2,258,000USD-31,317,000USD34,663,000USD138,447,000USD152,242,000USD434,593,000USD340,462,000USD
Unclassified Financing Cash Flow187,478,000USD664,015,000USD—449,130,000USD-766,067,000USD———
Unclassified Investing Cash Flow—3,658,000USD3,048,000USD45,074,000USD1,882,000USD45,797,000USD—-6,375,000USD
Change To Liabilities———5,928,000USD117,202,000USD222,000USD——
Change To Account Receivables————-188,158,000USD-120,111,000USD——
Change To Inventory————-24,102,000USD-37,965,000USD——
Cash And Cash Equivalents Changes————40,301,000USD———
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q2 2022Quarterly · 2022-06-30ProductCollaboration And Other21,125,000USD0001689813-22-000064
Q2 2022Quarterly · 2022-06-30ProductProduct193,954,000USD0001689813-22-000064
Q1 2022Quarterly · 2022-03-31ProductCollaboration And Other195,262,000USD0001689813-22-000041
Q1 2022Quarterly · 2022-03-31ProductProduct123,590,000USD0001689813-22-000041
Q2 2021Quarterly · 2021-06-30ProductCollaboration And Other0USD0001689813-22-000064
Q2 2021Quarterly · 2021-06-30ProductProduct92,933,000USD0001689813-22-000064
Q1 2021Quarterly · 2021-03-31ProductCollaboration And Other0USD0001689813-22-000041
Q1 2021Quarterly · 2021-03-31ProductProduct43,823,000USD0001689813-22-000041

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.